These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current development of alternative treatments for endothelial decompensation: Cell-based therapy. Rodríguez-Fernández S; Piñeiro-Ramil M; Castro-Viñuelas R; Sanjurjo-Rodríguez C; Álvarez-Portela M; Fuentes-Boquete IM; Rendal-Vázquez E; M Díaz-Prado S Exp Eye Res; 2021 Jun; 207():108560. PubMed ID: 33811914 [TBL] [Abstract][Full Text] [Related]
4. Generation and Feasibility Assessment of a New Vehicle for Cell-Based Therapy for Treating Corneal Endothelial Dysfunction. Okumura N; Kakutani K; Inoue R; Matsumoto D; Shimada T; Nakahara M; Kiyanagi Y; Itoh T; Koizumi N PLoS One; 2016; 11(6):e0158427. PubMed ID: 27355373 [TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure and corneal biomechanics in Fuchs' endothelial dystrophy and after posterior lamellar keratoplasty. Clemmensen K; Hjortdal J Acta Ophthalmol; 2014 Jun; 92(4):350-4. PubMed ID: 23607620 [TBL] [Abstract][Full Text] [Related]
6. Focus on cell therapy to treat corneal endothelial diseases. Faye PA; Poumeaud F; Chazelas P; Duchesne M; Rassat M; Miressi F; Lia AS; Sturtz F; Robert PY; Favreau F; Benayoun Y Exp Eye Res; 2021 Mar; 204():108462. PubMed ID: 33493477 [TBL] [Abstract][Full Text] [Related]
7. Patterns of corneal endothelialization and corneal clearance after descemet membrane endothelial keratoplasty for fuchs endothelial dystrophy. Dirisamer M; Dapena I; Ham L; van Dijk K; Oganes O; Frank LE; van der Wees J; Melles GR Am J Ophthalmol; 2011 Oct; 152(4):543-555.e1. PubMed ID: 21726849 [TBL] [Abstract][Full Text] [Related]
10. New therapeutic modality for corneal endothelial disease using Rho-associated kinase inhibitor eye drops. Koizumi N; Okumura N; Ueno M; Kinoshita S Cornea; 2014 Nov; 33 Suppl 11():S25-31. PubMed ID: 25289721 [TBL] [Abstract][Full Text] [Related]
11. In vivo confocal microscopy of Fuchs endothelial dystrophy before and after endothelial keratoplasty. Patel SV; McLaren JW JAMA Ophthalmol; 2013 May; 131(5):611-8. PubMed ID: 23471204 [TBL] [Abstract][Full Text] [Related]
12. Spontaneous corneal clearance despite graft detachment in descemet membrane endothelial keratoplasty. Balachandran C; Ham L; Verschoor CA; Ong TS; van der Wees J; Melles GR Am J Ophthalmol; 2009 Aug; 148(2):227-234.e1. PubMed ID: 19442962 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous corneal clearance despite graft removal in Descemet stripping endothelial keratoplasty in Fuchs endothelial dystrophy. Ziaei M; Barsam A; Mearza AA Cornea; 2013 Jul; 32(7):e164-6. PubMed ID: 23594769 [TBL] [Abstract][Full Text] [Related]
14. Preliminary clinical results of Descemet membrane endothelial keratoplasty. Melles GR; Ong TS; Ververs B; van der Wees J Am J Ophthalmol; 2008 Feb; 145(2):222-227. PubMed ID: 18061137 [TBL] [Abstract][Full Text] [Related]
15. Descemet's stripping with endothelial keratoplasty for special Fuchs' endothelial dystrophy in phakic eyes. Huang T; Luo Y; Wang Y; Hu A; Gao N Ophthalmic Res; 2011; 46(1):44-9. PubMed ID: 21212708 [TBL] [Abstract][Full Text] [Related]
16. ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue. Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Tsuchiya H; Hamuro J; Kinoshita S Am J Pathol; 2012 Jul; 181(1):268-77. PubMed ID: 22704232 [TBL] [Abstract][Full Text] [Related]
17. Experimental models of corneal endothelial cell therapy and translational challenges to clinical practice. Rolev K; Coussons P; King L; Rajan M Exp Eye Res; 2019 Nov; 188():107794. PubMed ID: 31518569 [TBL] [Abstract][Full Text] [Related]
18. Development of new therapeutic modalities for corneal endothelial disease focused on the proliferation of corneal endothelial cells using animal models. Koizumi N; Okumura N; Kinoshita S Exp Eye Res; 2012 Feb; 95(1):60-7. PubMed ID: 22067130 [TBL] [Abstract][Full Text] [Related]